Thursday 16 October, 2025
Objectives: The Neumann’s model of viral dynamics is the standard explanation for the biphasic decline of Hepatitis C virus (HCV)…
Read morePoster: Applications- Anti-infectives
Population Pharmacokinetics Of Vancomycin In Tunisian Patients
Thursday 16 October, 2025
Objectives: Vancomycin (VCM) is a glycopeptide antibiotic generally used for the treatment of gram-positive infections. For individualized optimal VCM dosage…
Read morePopulation pharmacokinetic analysis of ciprofloxacin in intensive care unit adult patients
Thursday 16 October, 2025
Objectives: To propose optimal dosage regimens for Intensive Care Unit (ICU) patients in order to achieve relevant PK/PD targets. It…
Read morePopulation Pharmacokinetics of Amikacin in Korean Clinical Population
Thursday 16 October, 2025
Objectives: This study aimed to develop a pharmacokinetic model of amikacin and to assess the influence of demographic and clinical…
Read moreEffect of Various Meals on the Population Pharmacokinetics of Rifapentine
Thursday 16 October, 2025
Objectives: Rifapentine and its primary metabolite, 25-desacetyl rifapentine, are active against mycobacterium tuberculosis. The objectives of this study were to…
Read moreOptimal Dosing of Miltefosine in Children and Adults with Leishmaniasis
Thursday 16 October, 2025
Introduction & Objectives: Pharmacokinetics and –dynamics (PK/PD) of miltefosine in children suffering from visceral leishmaniasis (VL), a fatal neglected parasitic…
Read moreApplications of Discrete-Event Dynamic Simulation in HCV Treatment Dynamics
Thursday 16 October, 2025
Backgrounds: The treatment objective in patients chronically infected with Hepatitis C Virus (HCV) is viral eradication, which allows patients to…
Read morePopulation pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin in critically ill septic patients
Thursday 16 October, 2025
Objectives: In severe sepsis and septic shock, appropriate antibiotic therapy plays a key role in the patient management. Since the…
Read moreApplication of systems pharmacology modeling approach to optimize Interferon therapy of hepatitis C
Thursday 16 October, 2025
Motivation: The interferon-based therapy is a common method of hepatitis C treatment. However, interferon-based therapy is lengthy (48 weeks), expensive…
Read moreApplication of pharmacokinetic-pharmacodynamic model to optimize dosing regime of antimicrobial drug Grammidin containing gramicidin S
Thursday 16 October, 2025
Objectives: To predict the dependence of antimicrobial effect of the gramicidin S applied as oral melting tablets on dosage, time…
Read more